Health & Fit: An Experimental Spit Test Could Identify Men Most at Risk of Prostate Cancer - - PressFrom - US
  •   
  •   
  •   

Health & Fit An Experimental Spit Test Could Identify Men Most at Risk of Prostate Cancer

23:07  11 june  2018
23:07  11 june  2018 Source:   gizmodo.com

More harm than help? 5 medical tests you probably don't need

  More harm than help? 5 medical tests you probably don't need Some screening exams do more harm than good for healthy people. Here's what to know.While it might seem smart screen for any disease you believe you're at risk for, some tests can do more harm than help when they're used in healthy people who show no signs of illness.

A test developed by scientists in the UK and US might someday be able to pinpoint the men most likely to get prostate cancer . A micrograph of prostatic acinar adenocarcinoma, the most common form of prostate cancer . Image: Nephron (Wikimedia Commons).

A test developed by scientists in the UK and US might someday be able to pinpoint the men most likely to get prostate cancer . A new study published Monday in Nature Genetics suggests the test can detect the one percent of men who are genetically most vulnerable to developing prostate cancer

a fabric surface: A micrograph of prostatic acinar adenocarcinoma, the most common form of prostate cancer. © Image: Nephron (Wikimedia Commons) A micrograph of prostatic acinar adenocarcinoma, the most common form of prostate cancer.

A test developed by scientists in the UK and US might someday be able to pinpoint the men most likely to get prostate cancer. A new study published Monday in Nature Genetics suggests the test can detect the one percent of men who are genetically most vulnerable to developing prostate cancer, a leading cause of cancer deaths among American men.

The international research team used a new DNA analysis technique to peer into the genes of more than 70,000 people enrolled in previous studies. Some 45,000 of the subjects had already developed prostate cancer, while 25,000 hadn’t. So the researchers compared the two groups, singling out any inherited genetic variations that might have contributed to their cancer risk. According to the authors, they managed to find 63 new variants never before associated with prostate cancer.

'Artificial mole' could warn of cancer: study

  'Artificial mole' could warn of cancer: study Swiss scientists have developed an experimental skin implant that darkens like a mole when it detects subtle changes in the body that may be an early warning sign of cancer, a study said Wednesday. The implant, or "biomedical tattoo," as researchers call it, has been tested in lab animals, lasts about a year and recognizes the four most common types of cancer: prostate, lung, colon and breast cancer.It works by reacting to the level of calcium in the blood, which rises when a tumor is developing. About 40 percent of cancers could theoretically be detected this way, researchers said.

But the saliva test could reveal especially high- risk people who need annual screening regardless of their PSA level, while ruling out low- risk people who don't need annual screening based on their genetic risk and PSA scores. Those people would only need screenings every two, five, and maybe even 10

The Prostate Cancer Foundation of Australia recommends that men with a family history of prostate cancer should be screened for prostate cancer via the But the saliva test could reveal especially high- risk people who need annual screening regardless of their PSA level, while ruling out low- risk

These results were then integrated with nearly a hundred genetic variants linked to prostate cancer previously found among 60,000 people to create a total genetic risk score. And finally, the researchers devised a test that uses a person’s saliva collected via cotton swab to detect these more than 150 variants.

“When you combine that score together, what you’re seeing is that individuals in the top one percentile have a six- to seven-fold higher risk of prostate cancer,” study author Fredrick Schumacher, an associate professor in the Department of Population & Quantitative Health Sciences at Case Western Reserve University, told Gizmodo. “So what this could help us do is come up with better screening rules.”

In the US, people over the age of 50 are generally screened for prostate cancer via the prostate-specific antigen (PSA) blood test. Those with a certain high level of PSA should be screened annually, while everyone else is advised to be screened every two years. But the saliva test could reveal especially high-risk people who need annual screening regardless of their PSA level, while ruling out low-risk people who don’t need annual screening based on their genetic risk and PSA scores. Those people would only need screenings every two, five, and maybe even 10 years, according to Schumacher.

US panel leaves prostate screening up to men, their doctors

  US panel leaves prostate screening up to men, their doctors Whether to get screened for prostate cancer is a question that men aged 55 to 69 should decide themselves in consultation with their doctors. New evidence suggests that PSA blood tests can slightly reduce the chances of dying from the disease for some men, so those decisions may be a little easier. Though screening can sometimes lead to drastic, needless treatment, the panel says that can sometimes be avoided with close monitoring when cancer is detected.

A new £7 spit test could help identify the men most at risk of prostate cancer - saving hundreds of lives a yearCredit: Getty - Contributor. These patients could then be given lifestyle advice, MRI scans and biopsies, so any potential tumour can be diagnosed and treated early. The £7 saliva test looks

A spit test to detect men at increased risk of prostate cancer has started early trials. The new DNA test looks for high- risk genes that are thought to affect one in every 100 They studied more than 140,000 men and identified 63 new genetic variations that can increase the risk of prostate cancer .

Together, the variants seem to account for nearly 30 percent of a person’s potential inherited risk of prostate cancer. Half of these high-risk men in the top one percent might be expected to develop prostate cancer, compared to the one in every 11 men with an average level of genetic risk. The top 10 percent have a risk 2.7 times higher, meaning as many as one in every four of these men could someday have prostate cancer.

For now, these numbers are only speculative. But some of the researchers are already planning to validate the test in the real world.

“If we can tell from testing DNA how likely it is that a man will develop prostate cancer, the next step is to see if we can use that information to help prevent the disease,” study author Ros Eeles, a professor of oncogenetics at The Institute of Cancer Research in the UK, said in a statement. “We now hope to begin a small study in [primary care] practices to establish whether genetic testing using a simple spit test could select high-risk men who might benefit from interventions to identify the disease earlier or even reduce their risk.”

How Can Men Lower Their Risk of Dying From Prostate Cancer?

  How Can Men Lower Their Risk of Dying From Prostate Cancer? As late-stage prostate cancer rates rise, men must grapple with questions about screening and treatment. For two decades prostate cancer deaths had been steadily declining. In 1993, about 39 in every 1,000 American men died from the cancer that starts in the walnut-sized gland between the bladder and the penis. Often that's where the cancer stops; but in some men it progresses and can be life-threatening. With advances in treatment, though, the death toll was halved to under 20 per 1,000 by 2012.

Simple DNA test might help to identify those men at greatest risk of developing the disease. “The reason we are particularly excited by the test is that this can be offered in general practice as a spit test to really try and identify who is most at risk of prostate cancer so we can offer them targeted

A genetic test that uses spit samples to predict which men are at greatest risk of prostate cancer could be ready for NHS use in two years, researchers say. Scientists discovered 63 new variations in the DNA code that increase men ’s risk of the deadly condition, after a study of more than 140,000

Because men in the US are already regularly screened for prostate cancer, the logistics of putting the saliva test through a trial are trickier, Schumacher said. US trials would probably need to take into account whether a man’s genetic risk score can lead to better outcomes in detecting or preventing prostate cancer in combination with his PSA score.

Since the newly published study included mostly men of European descent, they also need to find out how useful the risk score would be among men in other ethnic groups, particularly African American men, who are already more vulnerable to developing prostate cancer.

“We don’t want to put a trial out that’s just of white men,” Schumacher said. “We want to do something more comprehensive in the US.”

In addition to flagging the most at-risk men, this new list of genetic variants could be useful in efforts to prevent cancer from forming.

“The better understanding we have of the biology behind these risk scores, the more we can develop preventative treatments,” Schumacher said. The hypothetical drugs could be similar to those already in use for women at high risk of breast cancer.

[Nature Genetics]

Slideshow: 13 symptoms of serious health matters (Provided by Mom.me) 

13 Symptoms of Serious Health Matters 13 Symptoms of Serious Health Matters

Drinking Alcohol Can Lead To Aggressive Prostate Cancer .
Seven or more alcoholic beverages per week can increase a man's risk of having a high-grade tumor. Men who are diagnosed with prostate cancer, who also have a history of heavy drinking may be more likely to have an aggressive tumor, according to new research.A small study from the University of North Carolina, Chapel Hill, found that men who had a history of drinking seven or more alcoholic beverages per week had a three-fold increased risk of having a high-grade tumor, according to results published on Thursday in Cancer Prevention Research.

—   Share news in the SOC. Networks

Topical videos:

usr: 1
This is interesting!